Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Persistence of Twinrix Antibodies (16-20 Years)
NCT01000324Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2009
- Primary completion
- Jul 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis A (HAV), hepatitis B (HBV), sponsored by GSK. Started Nov 2009; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01000324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01000324.